Study of OB-002 in Patients With Refractory Metastatic Cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This is an open-label, non-randomized trial with OB-002 monotherapy dose escalation followed by a dose expansion in patients with metastatic colorectal, pancreatic, gastric, breast, or urothelial cancer who have progressed on two or more treatment regimens.
创建时间：
2024-01-15
